Dibrompropamidine
Names | |
---|---|
Preferred IUPAC name
4,4′-[Propane-1,3-diylbis(oxy)]bis(3-bromobenzene-1-carboximidamide) | |
Identifiers | |
3D model (
JSmol ) |
|
ChEMBL | |
ChemSpider | |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C17H18Br2N4O2 | |
Molar mass | 470.16 g/mol |
Pharmacology | |
D08AC01 (WHO) S01AX14 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Dibrompropamidine is an
Aventis Pharma
), Golden Eye (Typharm Ltd), and Brulidine (Manx Healthcare).
Characteristics
Dibrompropamidine is a white or almost white crystalline powder. It is odourless or almost odourless. Dibrompropamidine is freely soluble in water, soluble in glycerol, sparingly soluble in ethanol (96%), and practically insoluble in chloroform, in ether, in liquid paraffin and in fixed oils.
References
- ^ PubChem. "Dibrompropamidine". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-11-24.